|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01255 TATA HEALTH
Nominal 
0.300 0.000 (0.000%) | 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | |
| Turnover | 144,606 | -10.141% | 160,925 | 155,363 | 341,773 | 358,006 |
| Cost of Sales | (30,662) | -45.448% | (56,207) | (121,080) | (142,300) | (137,499) |
| Gross Profit | 113,944 | 8.810% | 104,718 | 34,283 | 199,473 | 220,507 |
| 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | (3,937) | -- | |
| Change in FV & Impairment on Others | (1,452) | -85.045% | (9,709) | (38,541) | (27,280) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (400) | -30.192% | (573) | 780 | 0 | (1) | |
| Profit / (Loss) before Taxation | 4,104 | -- | (69,143) | (172,683) | (67,446) | 6,583 | |
| Taxation | (898) | -31.503% | (1,311) | (396) | 544 | (498) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 6,407 | -33.901% | 9,693 | 21,210 | 5,977 | (7,834) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 9,613 | -- | (60,761) | (151,869) | (60,925) | (1,749) | |
| 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | |
| Net Finance Costs / (Income) | 1,049 | -33.099% | 1,568 | 3,007 | 2,559 | 1,606 |
| Depreciation & Amortisation | 12,017 | -12.686% | 13,763 | 24,414 | 32,324 | 3,698 |
| Directors' Emoluments | 8,624 | -9.288% | 9,507 | 10,218 | 5,757 | 4,886 |
| 2022/12 - Final | %Chg (Compare to Final) | 2021/12 | 2020/12 | 2019/12 | 2018/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2022/12 - Final | %Chg (Compare to Final) | 2021/12 | 2020/12 | 2019/12 | 2018/12 | |
| EPS (cts) | 4.000 | -- | -26.000 | -71.000 | -28.000 | -1.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.054 | -- | (0.021) | 0.001 | 0.077 | 0.085 |
| NBV per share ($) | 0.139 | -- | 0.095 | 0.047 | 0.751 | 1.027 |
| Remarks: | Real time quote last updated: 25/11/2024 11:51 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -12,327,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.050 |
| NBV Per Share ($) | HKD 0.093 |